针对癌症免疫治疗的cGAS-STING途径:从小分子激动剂到先进的纳米材料
Zhibin Guo1, Tingting Liu1, Qichao Gao1
1State Key Laboratory of Advanced Separation Membrane Materials, School of Chemistry & School of Chemical Engineering and Technology & School of Material Science and Engineering, Tiangong University, Tianjin 300387, P. R. China.
用小分子和纳米材料准干扰素基因 (cGAS-STING) 循环GMP-AMP合成酶刺激器通路,对癌症免疫疗法显示出希望. 这些策略旨在通过增强免疫反应,将冷瘤转化为热瘤.
科学领域:
- 免疫学 免疫学 免疫学
- 在瘤学瘤学.
- 纳米技术 纳米技术
背景情况:
- 干扰素基因 (cGAS-STING) 的循环GMP-AMP合成酶刺激通路通过感知DNA和产生细胞因子,对先天性和适应性抗瘤免疫至关重要.
- 这一途径弥合了先天性和适应性免疫,使其成为癌症免疫治疗的关键目标.
研究的目的:
- 审查针对癌症免疫疗法的cGAS-STING途径的最新进展.
- 探索用于激活cGAS-STING通路的小分子激动剂和基于纳米材料的治疗方法.
主要方法:
- 对旨在提高生物可用性和减少降解的小分子激动剂 (循环二核化物,非核化物) 的审查.
- 分析基于纳米材料的疗法 (无机和有机载体) 使用瘤微环境响应设计.
- 检查将cGAS-STING激活与DNA损伤,免疫细胞死亡和免疫检查点封锁协同作用的策略.
主要成果:
- 像ADU-S100和MSA-2这样的小分子激动剂显示出增强的STING激活和临床潜力.
- 纳米疗法通过放大cGAS-STING信号,有效地将免疫学上"冷"的瘤转化为"热"的表型.
- 在克服小分子的局限性和开发复杂的纳米平台方面取得了进展.
结论:
- 针对cGAS-STING通路具有精确癌症免疫治疗的变革潜力.
- 在平衡疗效与毒性,优化转移性疾病的分娩以及确保生物相容性方面,仍然存在挑战.
- 未来的研究应该专注于智能纳米载体,生物标志物驱动的分层和组合疗法.
更多相关视频
06:26Synthesis of Stimuli-responsive Nanogels using Aqueous One-step Crosslinking and Co-nanopolymerization
Published on: January 24, 2025
08:02Isolation of Primary Cancer-Associated Fibroblasts from a Syngeneic Murine Model of Breast Cancer for the Study of Targeted Nanoparticles
Published on: May 14, 2021
相关概念视频
Targeted Cancer Therapies
There are several types of targeted therapies against...
Tumor Immunotherapy
Cancer Vaccines
Cancer vaccines come in two categories: preventive (prophylactic) and treatment (active). Preventive vaccines, such as the Human Papillomavirus (HPV) vaccine, protect against viruses that cause certain...
Combination Therapies and Personalized Medicine
The combination of the drug acetazolamide and sulforaphane is a good example of combination therapy to treat cancer. The cells in the interior of a large tumor often die due to the hypoxic and...
Drugs that Stabilize Microtubules
